The nasal spray ... allergy. It should be seen as a rescue, but additional treatment may be needed in the ER," Gounder said. Gounder says the drug is meant to be available about eight weeks from ...

Opens in a new tab or window The first non-injectable emergency treatment for allergies is anticipated to hit shelves following FDA approval of the neffy epinephrine nasal spray. The product from ...

The Neffy nasal spray uses the same formula used in the traditional Epinephrine injection as a treatment for mild to severe ...

ARS Pharmaceuticals won Food and Drug Administration approval of its neffy nasal spray for the emergency treatment of allergic reactions, including life-threatening anaphylaxis. The FDA on Friday ...

According to ARS, the FDA regulators decided at the time that more data was needed to evaluate the safety of repeated doses of the nasal spray before it could be approved. "Neffy is epinephrine ...

allergy, and critical care in the FDA’s Center for Drug Evaluation and Research, in a statement. “The availability of epinephrine nasal spray may reduce barriers to rapid treatment of ...

a director for the FDA’s Center for Drug Evaluation and Research. Neffy is a single-dose nasal spray approved by drugmaker ARS Pharmaceuticals Inc. that administers epinephrine, the only life ...

Aug. 9, 2024 – An epinephrine nasal spray to treat serious allergic reactions may soon be available in the U.S. The FDA announced its approval of the nasal spray, called neffy, on Friday.